SPC25 and early-onset autosomal dominant Alzheimer disease: A cell-based assay revealed that the SPC25 can be a potential biomarker for Alzheimer’s disease as the expression level of SPC25 was significantly upregulated in the serum samples of patients with mild cognitive impairment (Zhang et al., 2018).